Australia markets closed

Salarius Pharmaceuticals, Inc. (SLRX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4951+0.0141 (+2.93%)
At close: 04:00PM EDT
0.5100 +0.01 (+3.01%)
After hours: 05:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.36M
Enterprise value -3.25M
Trailing P/E 1.80
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.45
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.25

Trading information

Stock price history

Beta (5Y monthly) 1.00
52-week change 3-72.35%
S&P500 52-week change 322.36%
52-week high 32.3100
52-week low 30.4300
50-day moving average 30.5626
200-day moving average 30.6904

Share statistics

Avg vol (3-month) 3108.54k
Avg vol (10-day) 323.64k
Shares outstanding 54.78M
Implied shares outstanding 64.78M
Float 83.59M
% held by insiders 16.08%
% held by institutions 15.50%
Shares short (15 Apr 2024) 4115.61k
Short ratio (15 Apr 2024) 40.4
Short % of float (15 Apr 2024) 42.73%
Short % of shares outstanding (15 Apr 2024) 42.68%
Shares short (prior month 15 Mar 2024) 414.39k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 322 July 2019
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 317 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-75.90%
Return on equity (ttm)-160.07%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -12.88M
Net income avi to common (ttm)-12.54M
Diluted EPS (ttm)-3.8400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.9M
Total cash per share (mrq)1.37
Total debt (mrq)289.64k
Total debt/equity (mrq)5.48%
Current ratio (mrq)5.02
Book value per share (mrq)1.34

Cash flow statement

Operating cash flow (ttm)-12.85M
Levered free cash flow (ttm)-8.99M